165 related articles for article (PubMed ID: 22951176)
1. Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas.
Reis ST; Leite KR; Mosconi Neto A; Pontes Júnior J; Viana NI; Antunes AA; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2012; 38(4):466-73. PubMed ID: 22951176
[TBL] [Abstract][Full Text] [Related]
2. The survival effect of E-cadherin and catenins in colorectal carcinomas.
Filiz AI; Senol Z; Sucullu I; Kurt Y; Demirbas S; Akin ML
Colorectal Dis; 2010 Dec; 12(12):1223-30. PubMed ID: 19575736
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
Ramburan A; Hadley GP; Govender D
Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas.
Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY
World J Gastroenterol; 2008 Oct; 14(37):5665-73. PubMed ID: 18837082
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
13. Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.
Clairotte A; Lascombe I; Fauconnet S; Mauny F; Félix S; Algros MP; Bittard H; Kantelip B
Am J Clin Pathol; 2006 Jan; 125(1):119-26. PubMed ID: 16483000
[TBL] [Abstract][Full Text] [Related]
14. Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.
Mohan A; Nalini V; Mallikarjuna K; Jyotirmay B; Krishnakumar S
Exp Eye Res; 2007 Apr; 84(4):781-9. PubMed ID: 17316610
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
16. Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma.
Scholten AN; Aliredjo R; Creutzberg CL; Smit VT
Int J Gynecol Cancer; 2006; 16(3):1379-85. PubMed ID: 16803534
[TBL] [Abstract][Full Text] [Related]
17. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
[TBL] [Abstract][Full Text] [Related]
19. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma.
Naka T; Oda Y; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
J Clin Pathol; 2001 Dec; 54(12):945-50. PubMed ID: 11729215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
